Table of Contents Table of Contents
Previous Page  388 / 1082 Next Page
Information
Show Menu
Previous Page 388 / 1082 Next Page
Page Background

S373

ESTRO 36 2017

_______________________________________________________________________________________________

validation) were 0.63, 0.68 and 0.66 respectively. Based

on this model, 2 groups risk were identified. The 3-year

OS, DFS and LRC were 88% (95CI: 67.4 – 100%), 78.7 % (63.6

– 97.3%) and 83.6% (95CI: 70.1 – 99.7%) for low-risk group

vs 45.5% (95CI: 23.8 – 86.8%), 33.3% (95CI: 15 – 74.2%) and

38.1% (95CI: 17.9 – 81.1%) for high-risk group (p<0.01)

(Figure 1 and 2).

Conclusion

TLG of the primary tumor and the distance between lymph

node and the primary tumor, weighted by the MTV of

lymph nodes, were correlated with LRC, DFS and OS.

These parameters seem to have a higher predictive value

than classical prognostics parameters, and may be useful

to tailoring the therapeutic approach in this type of

cancer.

PO-0719 The use of ultrasound bladder scanning in

cervical IMRT to reduce variability of uterine motion

S. Otter

1

, M. Hussein

1

, S. Why

1

, A. Franklin

1

, A. Stewart

1

1

Royal Surrey County Hospital, St Luke's Cancer Centre-

Oncology, Guildford, United Kingdom

Purpose or Objective

IMRT is being increasingly used over 3D conformal

radiotherapy in the treatment of locally advanced cervical

cancer. However, the uterus and cervix are mobile

structures whose positions vary depending on bladder and

rectal filling. The purpose of this study was to assess

whether the use of a portable US bladder scanning

protocol prior to each fraction of IMRT can reduce bladder

filling variability and therefore ultimately reduce cervical

/ uterine movement.

Material and Methods

Patients with locally advanced cervical cancer treated

with IMRT received daily CBCT imaging. The bladder was

retrospectively contoured on each CBCT. Ten patients

were treated using an US bladder scanning protocol (BVI

9400 bladder scan, Verathon). They had a daily pre-

treatment bladder scan (BS) and were imaged with CBCT

and then irradiated when the bladder volume fell in a pre-

determined individualized range based on planning CT

scans with empty and full bladder. If the bladder volume

was below the target range, patients were rescanned after

15 minutes, if it was above the range, they emptied their

bladder and recommenced bladder filling. Nine patients

were treated with a standard bladder filling protocol

which involved drinking 450ml water in 5 minutes then

treatment after 30 minutes. Results were analysed with a

Bland-Altman Plot to assess correlation between bladder

volume on US and on CBCT. Mann Whitney 1-tailed test

was used to assess whether the bladder scanning protocol

improved bladder filling consistency (the percentage of

radiotherapy fractions where the bladder volume on CBCT

fell within the pre-determined range).

Results

CBCTs and BS readings were available for 246 fractions of

radiotherapy in 10 patients in the BS cohort. 249 CBCTs

were available in 9 patients in the pre-BS cohort. The

mean difference between BS readings and bladder volume

on CBCT was -53.8cc, however the 95% CI band was wide

(38.6cc - 146.3cc) and there were a lot of outliers

suggesting a lack of statistical significance. This may be

related to a combination of: interoperator variability,

limited probe size, and differences in the time between

the BS readings and the CBCT. The percentage of fractions

that had bladder volumes within range were significantly

higher in the BS cohort (mean 70.5%) than the pre-BS

cohort (mean 38.5%, p=0.024). Two patients were

excluded from this analysis in the BS cohort as they had

empty bladder volumes greater than full bladder volumes

on planning CT.

Conclusion

The introduction of a bladder scanning protocol has

significantly improved the consistency of bladder filling

for each fraction of radiotherapy compared to a pre-

bladder scan cohort. This may enable a reduction in the

CTV-PTV margin in the future which would reduce the

volume of irradiated tissue and therefore hopefully reduce

toxicity.

PO-0720 CTV change during adaptive EBRT for cervix

cancer: is mid-treatment plan adaptation required?

D.D. Vignarajah

1

, M.C. Marbán

2

, K.T. Bath

3

, P.J. Hoskin

1

1

Mount Vernon Cancer Centre, Clinical Oncology,

Northwood, United Kingdom

2

Hospital Universitario Doctor Negrin, Radiation

Oncology, Las Palmas de Gran Canaria, Spain

3

Mount Vernon Cancer Centre, Radiotherapy Physics,

Northwood, United Kingdom

Purpose or Objective

Evaluation of clinical target volume (CTV) motion and

volumetric changes during cervical cancer external beam

radiotherapy (EBRT), to determine the value of mid-

treatment plan adaptation compared to pretreatment

plan adaptive radiotherapy.

Material and Methods

Patient Population

Patients undergoing pretreatment adaptive EBRT for

cervix cancer were eligible. Consistent bladder and bowel

preparation was used as per departmental protocol.

Analysis

Daily cone beam CT (CBCT) images were reviewed, with

the CTV and organs at risk (OARs) delineated on each

image set based on GEC-ESTRO guidelines.

Organ motion was assessed in 4 planes (anteriorly,

posteriorly, superiorly and inferiorly) at the same

anatomical points on each CBCT. Daily CTV volumes were

combined to form a weekly internal target volume (ITV),

with volume and motion assessed on a weekly basis. Based

on the changes noted, new PTV margins were added to the